MedTrace Logo

The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

NCT01384786 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4474

Last updated 2011-06-29

No results posted yet for this study

Summary

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.

The investigators have found that thyroid cancer is not overlooked.

Conditions

Sponsors & Collaborators

  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Anders Vej-Hansen · Herlev Hospital, Copenhagen, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2005-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01384786 on ClinicalTrials.gov